one8zero8 LLC Buys New Position in Danaher Corporation $DHR

one8zero8 LLC bought a new stake in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 17,097 shares of the conglomerate’s stock, valued at approximately $3,257,000.

A number of other institutional investors also recently made changes to their positions in DHR. High Note Wealth LLC increased its stake in shares of Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after acquiring an additional 47 shares during the period. First Command Advisory Services Inc. lifted its position in Danaher by 4.4% in the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after purchasing an additional 47 shares during the period. GW&K Investment Management LLC boosted its stake in Danaher by 8.4% during the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock valued at $138,000 after purchasing an additional 47 shares in the last quarter. Kestra Private Wealth Services LLC increased its position in shares of Danaher by 0.3% during the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after purchasing an additional 48 shares during the period. Finally, SOL Capital Management CO raised its stake in shares of Danaher by 2.7% in the 4th quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock worth $430,000 after buying an additional 50 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Trading Up 6.2%

NYSE:DHR opened at $211.92 on Thursday. The stock has a fifty day simple moving average of $194.30 and a 200 day simple moving average of $192.44. The firm has a market capitalization of $148.98 billion, a price-to-earnings ratio of 37.64, a price-to-earnings-growth ratio of 2.49 and a beta of 0.78. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.77 EPS. Sell-side analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts recently weighed in on DHR shares. Wells Fargo & Company decreased their target price on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. UBS Group reduced their price objective on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Morgan Stanley dropped their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Finally, Citigroup started coverage on shares of Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.